Drug Trial Radar · NCT07361289
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jan 15, 2026
Primary completion
Aug 22, 2028
Study completion Aug 28, 2028
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jan 23, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Conditions
- Hypertrophic Cardiomyopathy
Interventions
MavacamtenDrug
According to the product label
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Valsalva left ventricular outflow tract (LVOT) gradientTime frame: Week 48, Week 96
- Change from baseline in resting valsalva left ventricular outflow tract (LVOT) gradientTime frame: Week 48, Week 96
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 0003
Harbin, China · Not yet recruiting
Local Institution - 0010
Jinan, China · Not yet recruiting
Zhongshan Hospital Fudan University
Shanghai, China · Recruiting
Local Institution - 0008
Beijing, Beijing Municipality, China · Not yet recruiting
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University First Affiliated Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Second Afilliated Hospital of Hebei Medical University
Jiazhuang, Hebei, China · Recruiting
Local Institution - 0007
Zhengzhou, Henan, China · Not yet recruiting
Suzhou Municipal Hospital
Suzhou, Jiangsu, China · Recruiting
The Second Hospital of Jilin University
Changchun, Jilin, China · Recruiting
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China · Recruiting
Local Institution - 0013
Xi'an, Shan3xi, China · Withdrawn
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.